GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...

Let's discuss these factors in detail to understand if GSK’s stock is worth buying now. GSK has more than 20 marketed ...

GlaxoSmithKline (GSK) stock climbed on Thursday after the healthcare company announced that CEO Andrew Witty would retire in March 2017. GlaxoSmithKline (GSK) stock climbed on Thursday after the ...

Additionally, I believe GSK's stock will continue to rally thanks to progress made in developing its pipeline of experimental drugs and vaccines, including the FDA's approval of Jemperli in ...

GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine GSK announced positive phase 2 trial results for its mRNA seasonal flu vaccine, showing strong immune. Vandana ...

Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious ...

GSK PLC GSK shares slipped 1.84% to £15.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.72. Supported ...